As global markets navigate the complexities of easing inflation and robust bank earnings, major U.S. stock indexes have rebounded, with value stocks notably outperforming growth shares. This backdrop of cooling inflation and strong sector performance makes dividend stocks particularly appealing for investors seeking steady income streams amidst market volatility.
Top 10 Dividend Stocks
Name | Dividend Yield | Dividend Rating |
Peoples Bancorp (NasdaqGS:PEBO) | 5.11% | ★★★★★★ |
Tsubakimoto Chain (TSE:6371) | 4.32% | ★★★★★★ |
Guaranty Trust Holding (NGSE:GTCO) | 6.38% | ★★★★★★ |
CAC Holdings (TSE:4725) | 4.68% | ★★★★★★ |
Southside Bancshares (NYSE:SBSI) | 4.49% | ★★★★★★ |
Yamato Kogyo (TSE:5444) | 4.03% | ★★★★★★ |
Padma Oil (DSE:PADMAOIL) | 7.47% | ★★★★★★ |
GakkyushaLtd (TSE:9769) | 4.45% | ★★★★★★ |
E J Holdings (TSE:2153) | 4.02% | ★★★★★★ |
DoshishaLtd (TSE:7483) | 3.97% | ★★★★★★ |
Click here to see the full list of 1975 stocks from our Top Dividend Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Cheng De Lolo (SZSE:000848)
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Cheng De Lolo Company Limited manufactures and sells plant protein beverages, with a market cap of CN¥9.12 billion.
Operations: Cheng De Lolo Company Limited's revenue primarily comes from its Vegetable Protein Beverage segment, which generated CN¥3.08 billion.
Dividend Yield: 4.6%
Cheng De Lolo offers a dividend yield of 4.56%, placing it in the top 25% of CN market dividend payers, but its high cash payout ratio (101.3%) indicates dividends are not well covered by free cash flow. Despite a reasonable earnings payout ratio (69%), dividends have been volatile over the past decade and are considered unreliable. The company trades at good value, 16.2% below estimated fair value, yet recent buyback efforts have seen no shares repurchased so far.
- Delve into the full analysis dividend report here for a deeper understanding of Cheng De Lolo.
- According our valuation report, there's an indication that Cheng De Lolo's share price might be on the cheaper side.
Guilin Sanjin Pharmaceutical (SZSE:002275)
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Guilin Sanjin Pharmaceutical Co., Ltd. is involved in the research, production, and sale of traditional Chinese and natural medicines in China, with a market cap of CN¥7.98 billion.
Operations: Guilin Sanjin Pharmaceutical Co., Ltd.'s revenue segments include the research, production, and sale of traditional Chinese and natural medicines.
Dividend Yield: 4.4%
Guilin Sanjin Pharmaceutical's dividend yield of 4.37% ranks it among the top 25% in the CN market, supported by a manageable earnings payout ratio of 43.4%. However, its dividends have been volatile over the past decade and are considered unreliable, despite recent increases. The stock trades at a significant discount to its estimated fair value. Recent announcements affirm consistent quarterly dividends (CNY 2.50 per ten shares), with payments well-covered by cash flows at a cash payout ratio of 72.5%.
- Unlock comprehensive insights into our analysis of Guilin Sanjin Pharmaceutical stock in this dividend report.
- Our valuation report here indicates Guilin Sanjin Pharmaceutical may be undervalued.
Hua Eng Wire & Cable (TWSE:1608)
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Hua Eng Wire & Cable Co., Ltd. operates in Taiwan, focusing on the processing, manufacture, construction, and sale of wire, cable, and copper products with a market cap of NT$10.58 billion.
Operations: Hua Eng Wire & Cable Co., Ltd.'s revenue is primarily derived from its Cable segment at NT$4.90 billion, followed by Wire Materials at NT$3.19 billion and Copper Products at NT$3.06 billion.
Dividend Yield: 4%
Hua Eng Wire & Cable's dividend payments are well-covered by both earnings and cash flows, with payout ratios of 47.8% and 39.7%, respectively. Despite this, the dividends have been volatile over the past decade, indicating an unreliable track record. The stock trades significantly below its estimated fair value but offers a dividend yield lower than the top quartile in the Taiwan market. Recent earnings show growth in sales and net income compared to last year.
- Click here to discover the nuances of Hua Eng Wire & Cable with our detailed analytical dividend report.
- Upon reviewing our latest valuation report, Hua Eng Wire & Cable's share price might be too pessimistic.
Seize The Opportunity
- Click through to start exploring the rest of the 1972 Top Dividend Stocks now.
- Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
- Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Curious About Other Options?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SZSE:002275
Guilin Sanjin Pharmaceutical
Engages in the research, production, and sale of traditional Chinese and natural medicines in China.
Excellent balance sheet established dividend payer.